Back
Soleno Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
60
SLNO
Soleno Therapeutics
Last Price:
55.74
Seasonality Move:
33.56%
Sell
32
ALNY
Alnylam Pharmaceuticals
Last Price:
264.57
Seasonality Move:
10.85%
Buy
60
Soleno Therapeutics (SLNO)
is a Buy
Is Soleno Therapeutics a Buy, Sell or Hold?
- The current Soleno Therapeutics [SLNO] share price is $57.31. The Score for SLNO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SLNO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $268.95. The Score for ALNY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLNO Stock Price Chart
What is Soleno Therapeutics's stock price today?
-
The Soleno Therapeutics share price today is $57.31
The current trend is moderately bullish and SLNO is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $268.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight buying pressure.
SLNO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.64 | Buy |
| Relative Strength Index (14 RSI): | 60.56 | Buy |
| Chaikin Money Flow: | -278402 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.88 - 56.86) | Buy |
| Bollinger Bands (100): | (44.69 - 53.77) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.43 | Sell |
| Relative Strength Index (14 RSI): | 43.16 | Sell |
| Chaikin Money Flow: | 471990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (271.25 - 291.51) | Sell |
| Bollinger Bands (100): | (244.77 - 283.47) | Buy |
SLNO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57 | Buy |
| 20-day SMA: | 55.46 | Buy |
| 50-day SMA: | 52.36 | Buy |
| 200-day SMA: | 46.69 | Buy |
| 8-day EMA: | 57.05 | Buy |
| 20-day EMA: | 55.51 | Buy |
| 50-day EMA: | 52.9 | Buy |
| 200-day EMA: | 44.83 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 272.57 | Sell |
| 20-day SMA: | 282.31 | Sell |
| 50-day SMA: | 273.95 | Sell |
| 200-day SMA: | 208.77 | Buy |
| 8-day EMA: | 274.44 | Sell |
| 20-day EMA: | 277.16 | Sell |
| 50-day EMA: | 272.85 | Sell |
| 200-day EMA: | 229.82 | Buy |
Soleno Therapeutics Earnings Growth & SLNO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
Soleno Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||